cisplatin gefitinib erlotinib metformin paclitaxel oxaliplatin sanguinarine docetaxel glucocorticoid progesterone doxorubicin trastuzumab gemcitabine temozolomide adriamycin melatonin 131I panobinostat imatinib methotrexate dexamethasone 5-fluorouracil sunitinib cetuximab ATL-1 melphalan bortezomib tamoxifen calycosin DNMT1 inhibitor NSC141562 sorafenib sulforaphane 1,25(OH)2D3 Huaier conatumumab anisomycin fenofibrate fentanyl propofol lapatinib I-BET151 beta-Elemene compounds that damage DNA platinum corylin curcumin vincristine tigatuzumab chemotherapeutic agent etoposide (VP16) etoposide pirarubicin

Example : HOXA11-AS OR 221883 OR ENSG00000240990

Example : KDM1A OR 23028 OR ENSG00000004487

Submit  Reset 

cisplatin gefitinib erlotinib metformin paclitaxel oxaliplatin sanguinarine docetaxel glucocorticoid progesterone doxorubicin trastuzumab gemcitabine temozolomide adriamycin melatonin 131I panobinostat imatinib methotrexate dexamethasone 5-fluorouracil sunitinib cetuximab ATL-1 melphalan bortezomib tamoxifen calycosin DNMT1 inhibitor NSC141562 sorafenib sulforaphane 1,25(OH)2D3 Huaier conatumumab anisomycin fenofibrate fentanyl propofol lapatinib I-BET151 beta-Elemene compounds that damage DNA platinum corylin curcumin vincristine tigatuzumab chemotherapeutic agent etoposide (VP16) etoposide pirarubicin

Example : MEG3 OR 55384 OR ENSG00000214548

Example : CDH2 OR 1000 OR ENSG00000170558

Submit  Reset